semaglutide diabetes type 2 united states Semaglutide-based medications such as Ozempic and Wegovy are currently Semaglutide | Description, Uses, &

Marketed by: Novo Nordisk Inc., Plainsboro, NJ 08536 For information about OZEMPIC contact: Novo Nordisk Inc

Key Benefits: More Than Just Weight Loss The Downsides: Risks, Side Effects, and Concerns Who Shouldand ShouldntUse GLP-1 Drugs

Secondary efficacy outcomes The estimated mean SEM change in FPG from baseline to week 52 was 2.480.11 mmol/l in the IcoSema group and 1.410.11 mmol/l in the semaglutide group

Patients with type 2 diabetes who are overweight may find Semaglutide GLP-1 to be a useful therapy choice because of its ability to help patients lose weight

They also act on the digestive system to delay gastric emptying, delaying the release of food from the stomach and modulating brain activity to suppress appetite